ICLR
ICON plc
NASDAQ · Healthcare · Medical - Diagnostics & Research · IE
$164.11
−3.28%Next report
Analyst consensus
- Next report date
- Oct 28, 2026
- EPS estimate
- $2.69
- Revenue estimate
- $2.0B
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- $2.56
- EPS estimate
- $2.55
- Revenue actual
- $2.1B
- Revenue estimate
- $2.0B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 6
- Avg surprise (4Q)
- +1.6%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $181
- PT range
- $150 – $209
- Analysts
- 11
7 Buy3 Hold1 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 30, 2026 | $2.55 | $2.56 | Beat 0.39% | $2.1B |
| Jun 24, 2026 | $2.43 | $2.50 | Beat 2.88% | $2.1B |
| Oct 22, 2025 | $3.28 | $3.31 | Beat 0.91% | $2.0B |
| Jul 23, 2025 | $3.19 | $3.26 | Beat 2.19% | $2.0B |
| Apr 30, 2025 | $3.11 | $3.19 | Beat 2.57% | $2.0B |
| Feb 19, 2025 | $3.41 | $3.43 | Beat 0.59% | $2.0B |
| Oct 23, 2024 | $3.85 | $3.35 | Miss -12.99% | $2.0B |
| Jul 24, 2024 | $3.68 | $3.75 | Beat 1.90% | $2.1B |
| Feb 21, 2024 | $3.44 | $3.46 | Beat 0.58% | $2.1B |
| Oct 25, 2023 | $3.28 | $3.30 | Beat 0.61% | $2.1B |
| Jul 26, 2023 | $3.08 | $3.11 | Beat 0.97% | $2.0B |
| Feb 22, 2023 | $3.06 | $3.13 | Beat 2.29% | $2.0B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 28, 2026